FDA — authorised 7 August 1973
- Marketing authorisation holder: IMPAX LABS
- Status: approved
FDA authorised Pyrilamine on 7 August 1973
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 7 August 1973.
IMPAX LABS holds the US marketing authorisation.